Anti-Microbialvior BioteQ Co (ROCO:6864) FCF Margin %: -9,754.33% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6864 Anti-Microbial Savior BioteQ Co Ltd ROCO:6864
65 GF Score
Price NT$42.90
GF Value NT$25.49
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Anti-Microbialvior BioteQ Co FCF Margin %?

Anti-Microbialvior BioteQ Co ROCO:6864 -2.28% 65 FCF Margin % is -9,754.33% as of Dec. 2025. GuruFocus rates ROCO:6864 with a GF Score™ of 65/100 and a GF Value™ of NT$25.49 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 950 Biotechnology companies, Anti-Microbialvior BioteQ Co ranks worse than 94.21% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Anti-Microbialvior BioteQ Co's Free Cash Flow for the six months ended in Dec. 2025 was NT$-40.58 Mil. Anti-Microbialvior BioteQ Co's Revenue for the six months ended in Dec. 2025 was NT$0.42 Mil. Therefore, Anti-Microbialvior BioteQ Co's FCF Margin % for the quarter that ended in Dec. 2025 was -9,754.33%.

As of today, Anti-Microbialvior BioteQ Co's current FCF Yield % is -5.23%.

The historical rank and industry rank for Anti-Microbialvior BioteQ Co's FCF Margin % or its related term are showing as below:

ROCO:6864' s FCF Margin % Range Over the Past 10 Years
Min: -26606.82   Med: -11913.74   Max: -1424.03
Current: -11977.48

During the past 8 years, the highest FCF Margin % of Anti-Microbialvior BioteQ Co was -1424.03%. The lowest was -26606.82%. And the median was -11913.74%.

ROCO:6864's FCF Margin % is ranked worse than
94.21% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs ROCO:6864: -11977.48

Anti-Microbialvior BioteQ Co FCF Margin % Related Terms

Anti-Microbialvior BioteQ Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Anti-Microbialvior BioteQ Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anti-Microbialvior BioteQ Co FCF Margin % Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -26,606.82 -1,424.03 -6,837.77 -11,850.00 -11,977.48

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12,897.41 -9,693.33 -14,636.70 -15,166.55 -9,754.33

ROCO:6864 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anti-Microbialvior BioteQ Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Anti-Microbialvior BioteQ Co's FCF Margin % falls into.


ROCO:6864
65GF Score
Anti-Microbial Savior BioteQ Co Ltd ROCO:6864
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anti-Microbialvior BioteQ Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Anti-Microbialvior BioteQ Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-84.561/0.706
=-11,977.48 %

Anti-Microbialvior BioteQ Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-40.578/0.416
=-9,754.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -9,754.33% mean?
Anti-Microbialvior BioteQ Co (ROCO:6864) has a FCF Margin % of -9,754.33% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Anti-Microbialvior BioteQ Co and its competitors. According to the industry distribution chart, Anti-Microbialvior BioteQ Co ranks #895 out of 950 companies in the Biotechnology industry, placing it in the top 94.2%.
Is Anti-Microbialvior BioteQ Co's FCF Margin % too high?
Anti-Microbialvior BioteQ Co's current FCF Margin % is -9,754.33%. Based on the distribution chart, Anti-Microbialvior BioteQ Co ranks #895 out of 950 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Anti-Microbialvior BioteQ Co has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Anti-Microbialvior BioteQ Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Anti-Microbialvior BioteQ Co ranks #895 out of 950 companies for FCF Margin %. This places Anti-Microbialvior BioteQ Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Anti-Microbialvior BioteQ Co and its competitors. Anti-Microbialvior BioteQ Co's current FCF Margin % is -9,754.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anti-Microbialvior BioteQ Co stock overvalued right now?
Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co (ROCO:6864) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$25.49, compared to a current price of NT$42.90 — trading 68.3% above its estimated fair value. The current FCF Margin % is -9,754.33%. Anti-Microbialvior BioteQ Co's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Anti-Microbialvior BioteQ Co (ROCO:6864), the current FCF Margin % is -9,754.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Anti-Microbialvior BioteQ Co (ROCO:6864) Overvalued in 2026?

Based on GuruFocus' analysis, Anti-Microbialvior BioteQ Co stock appears to be overvalued. The current stock price of NT$42.90 is trading 68.3% above its estimated GF Value™ of NT$25.49. GuruFocus considers Anti-Microbialvior BioteQ Co to be Significantly Overvalued.

Key valuation signals for ROCO:6864:

  • FCF Margin %: -9,754.33%
  • GF Value™: NT$25.49 vs. price of NT$42.90 (68.3% above fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6864 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Anti-Microbialvior BioteQ Co Business Description

Address No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.
65GF Score

Get the complete analysis for ROCO:6864

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$42.90
Price
NT$25.49
GF Value